Trade Summary

6 days ago, Hindson Benjamin J., serving as See Remarks at 10x Genomics, Inc. (TXG), sold 11,595 shares at $24.44 per share, for a total transaction value of $283,399.19. Following this transaction, Hindson Benjamin J. now holds 502,000 shares of TXG.

This sale represents a 2.26% decrease in Hindson Benjamin J.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, May 22, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 27, 2026 at 5:56 PM ET, 5 days after the trade was made.

10x Genomics, Inc. operates in the HEALTHCARE sector, specifically within the HEALTH INFORMATION SERVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.